Literature DB >> 28938312

Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.

Eric K Chow1, Sandra DiBrito1, Xun Luo1, Corey E Wickliffe1, Allan B Massie1,2, Jayme E Locke3, Sommer E Gentry1,4, Jacqueline Garonzik-Wang1, Dorry L Segev1,2.   

Abstract

BACKGROUND: Recent changes in deceased donor organ allocation for livers (Share-35) and kidneys (kidney allocation system) have resulted in broader sharing of organs and increased cold ischemia time (CIT). Broader organ sharing however is not the only cause of increased CIT.
METHODS: This was a retrospective registry study of CIT in same-hospital liver transplants (SHLT, n = 4347) and same-hospital kidney transplants (SHKT, n = 9707) between 2004 and 2014.
RESULTS: In SHLT, median (interquartile range) CIT was 5.0 (3.5-6.5) hours versus 6.6 (5.1-8.4) hours in other-hospital LT. donation after circulatory death donors, donor biopsy, male recipient, recipient obesity, and previous transplant were associated with increased CIT. Model for End-Stage Liver Disease at transplant of 29+ or status 1a was associated with decreased CIT. SHLT CIT varied by Organ Procurement Organization and transplant-center (P < 0.01), with center median CIT ranging from 2.0 to 7.8 hours across 118 centers. In SHKT, CIT was 13.0 (8.5-19.0) hours versus 16.5 (11.3-22.6) hours in other-hospital KT. Overweight donors, donation after cardiac death donors, right-kidney, donor biopsy, recipient obesity, use of mechanical perfusion, additional KT procedures on the same day, and transplant center annual volume were associated with increased CIT. Older donor age, extended criteria donors, and underweight recipients were associated with decreased CIT. SHKT CIT varied by Organ Procurement Organization and transplant-center (P < 0.001), with center median CIT ranging from 3.3 to 29 hours across 206 centers. Transplant centers with longer SHKT also had longer SHLT (P = 0.01).
CONCLUSIONS: Same-hospital transplants already have a significant amount of CIT, even without transporting the organ to another hospital.

Entities:  

Mesh:

Year:  2018        PMID: 28938312      PMCID: PMC5820197          DOI: 10.1097/TP.0000000000001957

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft.

Authors:  C F Bryan; A M Luger; J Martinez; N Muruve; P W Nelson; G E Pierce; G Ross; C F Shield; B A Warady; M I Aeder; T S Helling
Journal:  Transplantation       Date:  2001-04-15       Impact factor: 4.939

2.  A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation.

Authors:  W D Irish; J N Ilsley; M A Schnitzler; S Feng; D C Brennan
Journal:  Am J Transplant       Date:  2010-10       Impact factor: 8.086

3.  Addressing geographic disparities in liver transplantation through redistricting.

Authors:  S E Gentry; A B Massie; S W Cheek; K L Lentine; E H Chow; C E Wickliffe; N Dzebashvili; P R Salvalaggio; M A Schnitzler; D A Axelrod; D L Segev
Journal:  Am J Transplant       Date:  2013-07-09       Impact factor: 8.086

4.  Early changes in liver distribution following implementation of Share 35.

Authors:  A B Massie; E K H Chow; C E Wickliffe; X Luo; S E Gentry; D C Mulligan; D L Segev
Journal:  Am J Transplant       Date:  2015-03       Impact factor: 8.086

5.  Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Shunji Nagai; Atsushi Yoshida; Marcelo Facciuto; Dilip Moonka; Marwan S Abouljoud; Myron E Schwartz; Sander S Florman
Journal:  Hepatology       Date:  2015-01-30       Impact factor: 17.425

6.  Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival.

Authors:  David D Lee; Amandeep Singh; Justin M Burns; Dana K Perry; Justin H Nguyen; C Burcin Taner
Journal:  Liver Transpl       Date:  2014-12       Impact factor: 5.799

7.  Major effects of delayed graft function and cold ischaemia time on renal allograft survival.

Authors:  Isabel Quiroga; Philip McShane; Dicken D H Koo; Derek Gray; Peter J Friend; Susan Fuggle; Christopher Darby
Journal:  Nephrol Dial Transplant       Date:  2006-02-20       Impact factor: 5.992

8.  Logistical Factors Influencing Cold Ischemia Times in Deceased Donor Kidney Transplants.

Authors:  Sussie Shrestha; Lisa Bradbury; Matthew Boal; James P Blackmur; Christopher J E Watson; Craig J Taylor; John L R Forsythe; Rachel Johnson; Lorna P Marson
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

9.  Impact of broader sharing on the transport time for deceased donor livers.

Authors:  Sommer E Gentry; Eric K H Chow; Corey E Wickliffe; Allan B Massie; Tabitha Leighton; Dorry L Segev
Journal:  Liver Transpl       Date:  2014-10       Impact factor: 5.799

10.  Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation.

Authors:  Agnes Debout; Yohann Foucher; Katy Trébern-Launay; Christophe Legendre; Henri Kreis; Georges Mourad; Valérie Garrigue; Emmanuel Morelon; Fanny Buron; Lionel Rostaing; Nassim Kamar; Michèle Kessler; Marc Ladrière; Alexandra Poignas; Amina Blidi; Jean-Paul Soulillou; Magali Giral; Etienne Dantan
Journal:  Kidney Int       Date:  2014-09-17       Impact factor: 10.612

View more
  2 in total

1.  An Initial Investigation of Unmanned Aircraft Systems (UAS) and Real-Time Organ Status Measurement for Transporting Human Organs.

Authors:  Joseph R Scalea; Stephen Restaino; Matthew Scassero; Gil Blankenship; Stephen T Bartlett; Norman Wereley
Journal:  IEEE J Transl Eng Health Med       Date:  2018-11-06       Impact factor: 3.316

2.  Association of Transit Time With Cold Ischemic Time in Kidney Transplantation.

Authors:  Andrew M Placona; Casey Humphries; Chris Curran; Woodlhey Ambroise; Jeffrey P Orlowski; Katrina Gauntt; Jen Wainright
Journal:  JAMA Netw Open       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.